Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Colla

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Blood|February 17, 2007
CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanismsFenghuang Zhan, Simona Colla, Xiaosong Wu, et al.
Experimental Hematology|October 28, 2010
The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxideManuela Abeltino, Sabrina Bonomini, Marina Bolzoni, et al.
Blood|June 4, 2005
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiationNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Blood|January 27, 2007
The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cellsSimona Colla, Fenghuang Zhan, Wei Xiong, et al.
Blood|May 10, 2005
IL-3 is a potential inhibitor of osteoblast differentiation in multiple myelomaLori A Ehrlich, Ho Yeon Chung, Irene Ghobrial, et al.
Cancer Research|August 16, 2008
CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesionsNicola Giuliani, Gina Lisignoli, Simona Colla, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
PDE4 Differential Expression Is a Potential Prognostic Factor and Therapeutic Target in Patients With Myelodysplastic Syndrome and Chronic Myelomonocytic LeukemiaAli N Chamseddine, Monica Cabrero, Yue Wei, et al.
Haematologica|November 4, 2006
CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survivalNicola Giuliani, Sabrina Bonomini, Paola Romagnani, et al.
Blood|October 7, 2003
Do human myeloma cells directly produce basic FGF?Simona Colla, Francesca Morandi, Mirca Lazzaretti, et al.
Leukemia & Lymphoma|May 7, 2015
Analysis of class I and II histone deacetylase gene expression in human leukemiaHui Yang, Sirisha Maddipoti, Andres Quesada, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Blood|February 17, 2007
CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanismsFenghuang Zhan, Simona Colla, Xiaosong Wu, et al.
Experimental Hematology|October 28, 2010
The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxideManuela Abeltino, Sabrina Bonomini, Marina Bolzoni, et al.
Blood|June 4, 2005
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiationNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Blood|January 27, 2007
The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cellsSimona Colla, Fenghuang Zhan, Wei Xiong, et al.
Blood|May 10, 2005
IL-3 is a potential inhibitor of osteoblast differentiation in multiple myelomaLori A Ehrlich, Ho Yeon Chung, Irene Ghobrial, et al.
Cancer Research|August 16, 2008
CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesionsNicola Giuliani, Gina Lisignoli, Simona Colla, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
PDE4 Differential Expression Is a Potential Prognostic Factor and Therapeutic Target in Patients With Myelodysplastic Syndrome and Chronic Myelomonocytic LeukemiaAli N Chamseddine, Monica Cabrero, Yue Wei, et al.
Haematologica|November 4, 2006
CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survivalNicola Giuliani, Sabrina Bonomini, Paola Romagnani, et al.
Blood|October 7, 2003
Do human myeloma cells directly produce basic FGF?Simona Colla, Francesca Morandi, Mirca Lazzaretti, et al.
Leukemia & Lymphoma|May 7, 2015
Analysis of class I and II histone deacetylase gene expression in human leukemiaHui Yang, Sirisha Maddipoti, Andres Quesada, et al.
Pageof 10